Skip to main content
main-content

Neuer Inhalt Free Registration

Gain full access to the latest clinical content available from Springer Nature

Editors' pick

23-08-2017 | E-learning | Collection

Treatment with biologicals in rheumatoid arthritis: An overview

The present review focuses on biological disease-modifying antirheumatic drugs (DMARDs) and targeted synthetic DMARDs regarding similarities and possible drug-specific advantages in the treatment of rheumatoid arthritis.
​​​​​​​Credit available: 1 (one) AMA PRA Category 1 Credit™
Valid until: August 2018

12-09-2017 | Rheumatoid arthritis | Feature | Article

At a glance: Trials evaluating baricitinib in RA

Our quick guide to the phase II and III trials of baricitinib for the treatment of rheumatoid arthritis. 

19-09-2017 | Osteoarthritis | News

Physical activity promotion needed after total knee or hip replacement

Changing sedentary behavior needs to be a focus for patients who undergo total knee or hip joint replacement, US researchers maintain.

Latest from across the site

22-09-2017 | ANCA-associated vasculitis | News

Active CV risk management needed in ANCA-associated vasculitis

A meta-analysis has highlighted the cardiovascular risk faced by patients with vasculitis associated with the presence of anti-neutrophil cytoplasmic antibodies.

Source:

Rheumatology 2017: Advance online publication

21-09-2017 | Rheumatoid arthritis | News

News in brief

Better PROs with baricitinib versus methotrexate

Baricitinib treatment is associated with greater improvements in patient-reported outcomes than methotrexate monotherapy, suggests an analysis of the RA-BEGIN trial.

19-09-2017 | Osteoarthritis | News

Physical activity promotion needed after total knee or hip replacement

Changing sedentary behavior needs to be a focus for patients who undergo total knee or hip joint replacement, US researchers maintain.

Source:

Arthritis Care Res 2017: Advance online publication

18-09-2017 | Rheumatoid arthritis | News

RA disease activity and severity play ‘important role’ in reducing CVD risk

Targeting factors such as inflammation and disease activity in patients with rheumatoid arthritis could help reduce their risk for cardiovascular disease, study findings suggest.

Source:

Ann Rheum Dis 2017; Advance online publication

15-09-2017 | Rheumatoid arthritis | News

News in brief

Predictors of medication adherence in RA patients identified

A Canadian research team has pinpointed several sociodemographic, disease, and treatment parameters associated with adherence to medication in patients with rheumatoid arthritis.

13-09-2017 | Giant cell arteritis | News

News in brief

Herpes zoster infection ‘one potential trigger’ for giant cell arteritis

Results of a US study suggest that herpes zoster infection is associated with an increased risk for giant cell arteritis, but antiviral treatment and vaccination are unlikely to reduce this risk.

Latest from us on Twitter

Meet our Editorial Board

image credits